for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Varian Medical Systems, Inc.

VAR.N

Latest Trade

117.53USD

Change

1.57(+1.35%)

Volume

620,082

Today's Range

116.01

 - 

117.77

52 Week Range

101.44

 - 

142.50

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
115.96
Open
117.00
Volume
620,082
3M AVG Volume
14.86
Today's High
117.77
Today's Low
116.01
52 Week High
142.50
52 Week Low
101.44
Shares Out (MIL)
91.06
Market Cap (MIL)
10,694.17
Forward P/E
24.93
Dividend (Yield %)
--

Next Event

Q4 2019 Varian Medical Systems Inc Earnings Release

Latest Developments

更多

Varian Expects To Benefit From Linear Accelerator Tariff Exclusion In China

Varian Announces Immaterial Impact Of Newly Proposed Tariffs

Varian Q3 NON-GAAP Earnings Per Share $1.32

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Varian Medical Systems, Inc.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, cardiac radioablation, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product. Through its subsidiary, Cooperative CL Enterprises, the Company distributes radiotherapy equipments in Taiwan.

Industry

Medical Equipment & Supplies

Contact Info

3100 Hansen Way Bldg 4A

+1.650.4934000

https://www.varian.com/

Executive Leadership

R. Andrew Eckert

Independent Chairman of the Board

Dow R. Wilson

President, Chief Executive Officer, Director

Timothy E. Guertin

Independent Vice Chairman of the board

Gary E. Bischoping

Chief Financial Officer, Senior Vice President - Finance

Chris A. Toth

President - Varian Oncology Systems

Key Stats

2.25 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

3.2K

2017

2.7K

2018

2.9K

2019(E)

3.2K
EPS (USD)

2016

4.680

2017

3.600

2018

4.420

2019(E)

4.651
Price To Earnings (TTM)
31.86
Price To Sales (TTM)
3.40
Price To Book (MRQ)
6.13
Price To Cash Flow (TTM)
25.74
Total Debt To Equity (MRQ)
23.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
17.30
Return on Equity (TTM)
9.53

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up